» Articles » PMID: 12640660

Biochemical Recurrence Following Radical Prostatectomy: a Comparison Between Prostate Cancers Located in Different Anatomical Zones

Overview
Journal Prostate
Date 2003 Mar 18
PMID 12640660
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To assess whether differences of biochemical recurrence after radical prostatectomy exist between prostate cancers located in the transition zone (TZ) and peripheral zone (PZ).

Methods: The 5-year biochemical recurrence rate of 307 patients was evaluated. A serum prostate specific antigen (PSA) level > or =0.1 ng/ml was defined as biochemical failure. Cancers were characterized by the location of the largest tumor area as TZ or PZ cancers. Pure PZ cancers were matched to TZ cancers by comparable pathological tumor stage, Gleason score, and surgical margin status.

Results: In 63 (20.5%) patients the largest tumor area was located in the TZ. A Kaplan-Meier analysis of the matched pairs calculated an 80% actuarial cure rate of TZ cancers compared to 89% of pure PZ cancers (log-rank test P = 0.742).

Conclusions: TZ and pure PZ cancers matched by comparable pathological tumor stage, Gleason score, and surgical margin status showed no statistical difference in regard to biochemical cure following radical prostatectomy.

Citing Articles

Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis.

Ali A, Elumalai T, Venkatesulu B, Hekman L, Mistry H, Sachdeva A BMJ Oncol. 2025; 3(1):e000193.

PMID: 39886173 PMC: 11234997. DOI: 10.1136/bmjonc-2023-000193.


The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy.

Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X Res Rep Urol. 2024; 16:205-214.

PMID: 39345801 PMC: 11430843. DOI: 10.2147/RRU.S477396.


Differences in the pathogenetic characteristics of prostate cancer in the transitional and peripheral zones and the possible molecular biological mechanisms.

Yu X, Liu R, Song L, Gao W, Wang X, Zhang Y Front Oncol. 2023; 13:1165732.

PMID: 37456243 PMC: 10348634. DOI: 10.3389/fonc.2023.1165732.


Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.

Baba H, Sakamoto S, Zhao X, Yamada Y, Rii J, Fujimoto A Cancers (Basel). 2022; 14(23).

PMID: 36497304 PMC: 9740872. DOI: 10.3390/cancers14235823.


Prostate zones and cancer: lost in transition?.

Ali A, Du Feu A, Oliveira P, Choudhury A, Bristow R, Baena E Nat Rev Urol. 2021; 19(2):101-115.

PMID: 34667303 DOI: 10.1038/s41585-021-00524-7.